Corcept Therapeutics, Inc. (CORT)

46.16 +2.20 (+5.00%) USD  |  NASDAQ  |  Apr 17, 16:00
46.63 +0.47 (+1.02%) Pre-Market: 20:00
More

Corcept Therapeutics Total Operating Expenses (% of Quarterly Revenues)

Total Operating Expenses (% of Quarterly Revenues) Chart

View Total Operating Expenses (% of Quarterly Revenues) for CORT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Operating Expenses (% of Quarterly Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Operating Expenses (% of Quarterly Revenues) Range, Past 5 Years

View Total Operating Expenses (% of Quarterly Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Operating Expenses (% of Quarterly Revenues) Benchmarks

View Total Operating Expenses (% of Quarterly Revenues) Benchmarks
Start Trial
Merck & Co., Inc. Upgrade
Terns Pharmaceuticals, Inc. --
Integer Holdings Corp. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade
Catalyst Pharmaceuticals, Inc. Upgrade